Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-015088
Filing Date
2019-08-09
Accepted
2019-08-09 11:48:53
Documents
81
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0619_americanbrivision.htm 10-Q 801582
2 CERTIFICATION f10q0619ex31-1_american.htm EX-31.1 11019
3 CERTIFICATION f10q0619ex31-2_american.htm EX-31.2 10441
4 CERTIFICATION f10q0619ex32-1_american.htm EX-32.1 3822
5 CERTIFICATION f10q0619ex32-2_american.htm EX-32.2 3523
  Complete submission text file 0001213900-19-015088.txt   5227188

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE abvcd-20190630.xml EX-101.INS 893956
7 XBRL SCHEMA FILE abvcd-20190630.xsd EX-101.SCH 64193
8 XBRL CALCULATION FILE abvcd-20190630_cal.xml EX-101.CAL 70070
9 XBRL DEFINITION FILE abvcd-20190630_def.xml EX-101.DEF 222471
10 XBRL LABEL FILE abvcd-20190630_lab.xml EX-101.LAB 392539
11 XBRL PRESENTATION FILE abvcd-20190630_pre.xml EX-101.PRE 342057
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-91436 | Film No.: 191012016
SIC: 2834 Pharmaceutical Preparations